Update in the management of gastroenteropancreatic neuroendocrine tumors
Cancer · 15.09.2024 · 130 (18) · 3090-3105
DOI: 10.1002/cncr.35463 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cancer, online erschienen am 16.07.2024. Verfasst von Andrew J H Sedlack und 9 weiteren Autor:innen. Beteiligte Einrichtung: Medical Scientist Training Program, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA. Hauptthemen laut MEDLINE: Neuroendocrine Tumors, Pancreatic Neoplasms, Stomach Neoplasms, Intestinal Neoplasms. Die Arbeit wurde bisher 28-mal zitiert (Crossref) und nennt 146 Literaturangaben. Gefördert von: NCI NIH HHS.
Abstract (Originalsprache)
Neuroendocrine neoplasms are a diverse group of neoplasms that can occur in various areas throughout the body. Well‐differentiated neuroendocrine tumors (NETs) most often arise in the gastrointestinal tract, termed gastroenteropancreatic neuroendocrine tumors (GEP‐NETs). Although GEP‐NETs are still uncommon, their incidence and prevalence have been steadily increasing over the past decades. The primary treatment for GEP‐NETs is surgery, which offers the best chance for a cure. However, because GEP‐NETs are often slow‐growing and do not cause symptoms until they have spread widely, curative surgery is not always an option. Significant advances have been made in systemic and locoregional treatment options in recent years, including peptide‐receptor radionuclide therapy with α and β emitters, somatostatin analogs, chemotherapy, and targeted molecular therapies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Medical Scientist Training Program, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.
- Developmental Therapeutics Branch, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland, USA.
- Radiology and Imaging Sciences, Clinical Center, National Institutes of Health, Bethesda, Maryland, USA.
- Memorial Sloan Kettering Cancer Center, New York, New York, USA.
- Odette Cancer Centre, Sunnybrook Health Sciences Centre, East York, Ontario, Canada.
- Departamento de Oncologia Clínica, AC Camargo Cancer Center, Sao Paolo, Brazil.
ORCID-Profile: Andrew J H Sedlack, Julie Hallet, Jaydira Del Rivero
Förderung
- NCI NIH HHS
Zitieren
APA
Sedlack, A. J. H., Varghese, D. G., Naimian, A., Yazdian Anari, P., Bodei, L., Hallet, J., Riechelmann, R. P., Halfdanarson, T., Capdevilla, J., & Del Rivero, J. (2024). Update in the management of gastroenteropancreatic neuroendocrine tumors. Cancer, 130(18), 3090-3105. https://doi.org/10.1002/cncr.35463
Vancouver
Sedlack AJH, Varghese DG, Naimian A, Yazdian Anari P, Bodei L, Hallet J, et al. Update in the management of gastroenteropancreatic neuroendocrine tumors. Cancer. 2024;130(18):3090-3105. doi:10.1002/cncr.35463
BibTeX
@article{Sedlack2024,
author = {Sedlack, Andrew J H and Varghese, Diana Grace and Naimian, Amirkia and Yazdian Anari, Pouria and Bodei, Lisa and Hallet, Julie and Riechelmann, Rachel P and Halfdanarson, Thor and Capdevilla, Jaume and Del Rivero, Jaydira},
title = {Update in the management of gastroenteropancreatic neuroendocrine tumors},
journal = {Cancer},
year = {2024},
volume = {130},
number = {18},
pages = {3090--3105},
doi = {10.1002/cncr.35463}
}
EUVIMED